These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1806241

  • 41. [Acute colitis after treatment with lincomycin and clindamycin].
    Fournet J, Rollux R, Thery JP, Hostein J, Girona GC, Bonnet-Eymard JH.
    Med Chir Dig; 1977; 6(5):277-80. PubMed ID: 916761
    [No Abstract] [Full Text] [Related]

  • 42. Lincomycin and clindamycin in the treatment of infections of the hand.
    Sneddon J.
    Practitioner; 1972 Dec; 209(254):787-93. PubMed ID: 4654750
    [No Abstract] [Full Text] [Related]

  • 43. [Microbiological, pharmacological and clinical principles of clindamycin therapy].
    Modde H.
    Schweiz Med Wochenschr; 1971 Nov 13; 101(45):1632-3. PubMed ID: 4947153
    [No Abstract] [Full Text] [Related]

  • 44. Clindamycin phosphate in the treatment of endometritis due to anaerobic bacteria.
    Creatsas G, Pavlatos M, Aravantinos D, Milingos S, Kaskarelis D.
    Int J Clin Pharmacol Ther Toxicol; 1981 May 13; 19(5):203-5. PubMed ID: 7251234
    [Abstract] [Full Text] [Related]

  • 45. Prevention of dry socket with clindamycin. A retrospective study.
    Kupfer SR.
    N Y State Dent J; 1995 May 13; 61(6):30-3. PubMed ID: 7624100
    [Abstract] [Full Text] [Related]

  • 46. Use of clindamycin in lower respiratory tract infections.
    Schreiner A.
    Scand J Infect Dis Suppl; 1984 May 13; 43():56-61. PubMed ID: 6598521
    [Abstract] [Full Text] [Related]

  • 47. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.
    Wakiyama Y, Kumura K, Umemura E, Masaki S, Ueda K, Watanabe T, Yamamoto M, Hirai Y, Ajito K.
    J Antibiot (Tokyo); 2016 Jun 13; 69(6):428-39. PubMed ID: 26669751
    [Abstract] [Full Text] [Related]

  • 48. Tetracyclines, macrolides, lincosamides & chloramphenicol.
    Ruiz NM, Rámirez-Ronda CH.
    Bol Asoc Med P R; 1990 Jan 13; 82(1):8-17. PubMed ID: 2180420
    [Abstract] [Full Text] [Related]

  • 49. [The role of dalacin C in the management of odontogenic inflammations].
    Gyenes V, Sülle T.
    Fogorv Sz; 1995 May 13; 88(5):163-6. PubMed ID: 8522010
    [Abstract] [Full Text] [Related]

  • 50. Abdominal trauma, anaerobes, and antibiotics.
    Thadepalli H, Gorbach SL, Broido PW, Norsen J, Nyhus L.
    Surg Gynecol Obstet; 1973 Aug 13; 137(2):270-6. PubMed ID: 4723349
    [No Abstract] [Full Text] [Related]

  • 51. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M, Carrera E, Palma A, Berrios G, Weintraub A, Nord CE.
    Rev Esp Quimioter; 1999 Dec 13; 12(4):332-9. PubMed ID: 10855012
    [Abstract] [Full Text] [Related]

  • 52. The newer antibiotics.
    Ries K, Kaye D.
    Med Clin North Am; 1973 Jul 13; 57(4):1065-78. PubMed ID: 4576147
    [No Abstract] [Full Text] [Related]

  • 53. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L, Edén T.
    Acta Chir Scand; 1981 Jul 13; 147(5):339-46. PubMed ID: 7324760
    [Abstract] [Full Text] [Related]

  • 54. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.
    Wybo I, Piérard D, Verschraegen I, Reynders M, Vandoorslaer K, Claeys G, Delmée M, Glupczynski Y, Gordts B, Ieven M, Melin P, Struelens M, Verhaegen J, Lauwers S.
    J Antimicrob Chemother; 2007 Jan 13; 59(1):132-9. PubMed ID: 17095529
    [Abstract] [Full Text] [Related]

  • 55. [Pseudomembranous colitis induced by clindamycin-lincomycin combination. Description of a clinical case].
    Cavanenghi D, Morra C, Grassini M, Sorisio V.
    Minerva Dietol Gastroenterol; 1985 Jan 13; 31(2):343-5. PubMed ID: 4034041
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Update on clindamycin in the management of bacterial, fungal and protozoal infections.
    Guay D.
    Expert Opin Pharmacother; 2007 Oct 13; 8(14):2401-44. PubMed ID: 17927492
    [Abstract] [Full Text] [Related]

  • 58. Lincosamides: Chemical structure, biosynthesis, mechanism of action, resistance, and applications.
    Spížek J, Řezanka T.
    Biochem Pharmacol; 2017 Jun 01; 133():20-28. PubMed ID: 27940264
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Lincomycin disc susceptibility testing criteria.
    Fuchs PC, Barry AL.
    J Antimicrob Chemother; 1990 Jun 01; 25(6):1024-5. PubMed ID: 2370238
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.